Global Bone Biopsy Market, 2023-2028

Market Overview

According to Tanalyze, the global bone biopsy market is predicted to grow by US$ 177 million between 2023 and 2028, with a compound annual growth rate (CAGR) of 5.2% during the forecast period. Bone biopsy is a medical procedure that involves removing a small sample of bone tissue from the patient’s body for diagnostic purposes. The biopsy is typically performed with a needle that is guided by imaging technology, such as X-rays, CT scans, or MRI scans, to accurately locate the area of interest. The sample of bone tissue is then examined under a microscope by a pathologist to diagnose bone-related diseases or abnormalities. Bone biopsy is often used to diagnose bone tumors, infections, fractures, genetic bone disorders, and other bone-related conditions. The procedure may be performed in a hospital or clinic setting, and in some cases, it may be done on an outpatient basis. Bone biopsy may cause some discomfort, but it is generally considered a safe and minimally invasive procedure compared to other types of biopsies.

The report presents current market size data and forecasts on important market aspects such as growth potential and revenue-contributing segments for bone biopsy. The global bone biopsy market is segmented based on type, guidance, end user, and region. Needle biopsy and open biopsy are the two types of bone biopsy, with needle biopsy being the largest contributor to the market share, accounting for over 65.2% of the total market. CT-guided bone biopsy and MR-guided bone biopsy are the two guidance methods, with the former capturing the largest market share in 2022.

Research Coverage

The bone biopsy market is segmented as below:
By type: needle biopsy, and open biopsy
By guidance: CT-guided bone biopsy and MR-guided bone biopsy
By end user: hospitals and clinics, surgery centers and others
By geography: North America, Europe, Asia Pacific, and Rest of World (ROW)

Key Driving Factors
The bone biopsy market is projected to experience growth over the forecast period due to multiple key driving factors:

Increasing Prevalence of Bone-Related Disorders: The bone biopsy market is being driven by the rise in bone-related disorders, such as bone cancer, osteoporosis, and other metabolic disorders, which require early and accurate diagnosis. The need for early diagnosis is resulting in an increase in demand for bone biopsy procedures.

Technological Advancements: Diagnostic imaging technologies, such as CT scans, MRI, and ultrasound, have experienced significant advancements, which have led to more accurate bone biopsy procedures. The development of minimally invasive biopsy techniques has also boosted the growth of the bone biopsy market by reducing the complications associated with open biopsy procedures.

Growing Demand for Minimally Invasive Procedures: The demand for minimally invasive bone biopsy procedures has risen as a result of the patient preference for less pain, fast recovery, and less hospital costs. This preference by patients has driven the demand for minimally invasive bone biopsy procedures, causing an increase in the growth of the bone biopsy market.

Increasing Geriatric Population: Nowadays, the aging population is more susceptible to bone-related disorders, resulting in a rise in the demand for bone biopsy procedures. As the global population continues to age, the demand for bone biopsy procedures is expected to increase, leading to the growth of the bone biopsy market.

Rising Awareness and Healthcare Expenditure: The growth of the bone biopsy market is also attributed to increasing awareness of the importance of early diagnosis and treatment of bone-related disorders. The growth is further supported by rising healthcare expenditure as healthcare providers are investing more in diagnostic technologies and increasing the adoption of bone biopsy procedures.

Competitive Landscape

The global bone biopsy market has a competitive landscape with several key players operating in the market. Some of the prominent players include Argon Medical Devices Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Biopsybell S.r.l., Cardinal Health Inc., Cook Group Incorporated, Kimal PLC, Laurane Medical LLC, Meditech Devices Pvt Ltd, Merit Medical Systems Inc., Moller Medical GmbH, Remington Medical Inc., SOMATEX Medical Technologies GmbH (Hologic Inc.), Stryker Corporation, Teleflex Incorporated, Tsunami Medical S.r.l., and Zamar Care z.o.o. These players compete based on various factors such as technological advancements, product innovation, pricing, marketing strategies, and distribution channels. The competitive landscape of the global bone biopsy market is constantly evolving, and new players are entering the market, increasing competition among the players.

Table of Contents

1. Introduction
1.1 Definition
1.2 Market Segment
2. Research Methodology
2.1 Primary Research
2.2 Secondary Research
2.3 Information Sources
3. Market Overview
4. Global Bone Biopsy Market – Type Analysis
4.1 Needle biopsy
4.2 Open biopsy
5. Global Bone Biopsy Market – Guidance Analysis
5.1 CT-guided bone biopsy
5.2 MR-guided bone biopsy
6. Global Bone Biopsy Market – End User Analysis
6.1 Hospitals and clinics
6.2 Surgery centers
6.3 Others
7. Global Bone Biopsy Market – Geography Analysis
7.1 North America
7.2 Europe
7.3 Asia Pacific
7.4 Rest of the World (RoW)
8. Company Profiles
8.1 Argon Medical Devices, Inc.
8.2 B. Braun Melsungen AG
8.3 Becton, Dickinson and Company
8.4 Biopsybell S.r.l.
8.5 Cardinal Health, Inc.
8.6 Cook Group Incorporated
8.7 Kimal PLC
8.8 Laurane Medical LLC
8.9 Meditech Devices Pvt Ltd
8.10 Merit Medical Systems, Inc.
8.11 Moller Medical GmbH
8.12 Remington Medical Inc.
8.13 SOMATEX Medical Technologies GmbH (Hologic, Inc.)
8.14 Stryker Corporation
8.15 Teleflex Incorporated
8.16 Tsunami Medical S.r.l.
8.17 Zamar Care z.o.o.
DISCLAIMER

Companies Mentioned

Argon Medical Devices, Inc.
B. Braun Melsungen AG
Becton, Dickinson and Company
Biopsybell S.r.l.
Cardinal Health, Inc.
Cook Group Incorporated
Kimal PLC
Laurane Medical LLC
Meditech Devices Pvt Ltd
Merit Medical Systems, Inc.
Moller Medical GmbH
Remington Medical Inc.
SOMATEX Medical Technologies GmbH (Hologic, Inc.)
Stryker Corporation
Teleflex Incorporated
Tsunami Medical S.r.l.
Zamar Care z.o.o.